Home
University & Research Institutions

Sector: University & Research Institutions

Historic CRISPR drug approval heralds new era in Cas9 IP wars

Green light for first ever Cas9 therapy ushers in next phase of licensing and litigation efforts.

CRISPR-Cas9 drugmakers like Vertex should come to the table early, says ToolGen’s IP chief

Chief Legal Officer Yoori Kim argues that current patent uncertainty should fuel rather than thwart licensing deals

Patent transactions in Q2 2023

The surge is due to 9,702 US patent assets involved in the BlackBerry sale to Key Patent Innovations, which runs Malikie Innovations, according to the AST Patent Deals Report for Q2 2023

Latest content

Legal challenges to the PTAB’s NHK-Fintiv discretionary denial regime mount

Life sciences companies are among those leading the way in going to court to get the current rules struck down

20 August 2021

Brazil on the cusp of passing landmark compulsory technology transfer law

Life sciences innovators may be compelled to hand over trade secrets, data and biological materials under legislation that now only requires President Bolsonaro’s signature to become law

19 August 2021

New study shows surge in data-driven and computer-assisted healthcare patents

Boom in digital healthcare and bioinformatics IP requires strategic adjustments in both the life sciences and high-tech arenas

17 August 2021

mRNA IP will be hot property beyond the pandemic

$3.2 billion Sanofi deal is unlikely to be the last as Big Pharma seeks to consolidate its position in the cutting-edge field

12 August 2021

Pharma should make good use of the UPC from the beginning, says Bayer’s head of IP

There are a lot of potential benefits to the new system, but we need to integrate it into our strategies to make sure it works, explains Joerg Thomaier

11 August 2021

Healthcare Royalty Partners’ $750 million IPO to be next milestone for a booming market

The company is hoping to raise cash to help expand its purchasing power when acquiring pharmaceuticals revenue streams

05 August 2021

Ofinno's Honda and Xiaomi deals point to strong 5G patent secondary market

The Virginia-based R&D outfit has made a string of sales to big names in consumer tech over recent months, with Samsung another prominent customer

26 July 2021

UK Supreme Court quashes £220 million third-party lawsuit against patent litigant

Country’s National Health Service fails to overturn rules on damages sought by healthcare providers affected by failed enforcement

07 July 2021

Everything you need to know about SCOTUS’ Minerva ruling on assignor estoppel

In a 5-4 decision the court’s justices significantly narrowed the scope of the doctrine that prevents assignors from challenging patents in court.

01 July 2021

University and Big Pharma JV’s $145 million take-off is a big boost for tech transfer dealmaking

Apollo Therapeutics is an innovative biotech formed by three UK universities and three major companies, with a promising model for creating and monetising life sciences IP

29 June 2021

Unlock unlimited access to all IAM content